Feasibility study of Bismuth Subsalicylate (BSS) as an addition to standard of care for COVID-19 therapy

Por Mary Beth Yacyshyn, PhD, James Collins, PhD, Michelle Chua, PhD, Angela Siegwald, MSN, Sara Yacyshyn, MD, Valerie Briones-Pryor, MD, Bruce Yacyshyn, MD
Publicado em 2022-01-01